Aarti Drugs (India) Investor Sentiment

AARTIDRUGS   386.75  24.75  6.01%   
Slightly above 62% of Aarti Drugs' investor base is looking to short. The analysis of overall sentiment of trading Aarti Drugs Limited stock suggests that many investors are alarmed at this time. Aarti Drugs' investing sentiment overview a quick insight into current market opportunities from investing in Aarti Drugs Limited. Many technical investors use Aarti Drugs Limited stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aarti Drugs stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Aarti daily returns and investor perception about the current price of Aarti Drugs Limited as well as its diversification or hedging effects on your existing portfolios.
  
few days ago at news.google.com         
Aarti Drugs shares rose 12 percent in fag end of trade today, heres why - Business Today
Google News at Macroaxis
few days ago at news.google.com         
Aarti Drugs Faces Significant Volatility Amid Sustained Stock Weakness in October 2023 - MarketsMojo
Google News at Macroaxis
over a week ago at news.google.com         
Aarti Drugs Limited Receives an Order Refer with GST DRC-07 from the CGST C.Ex. Authority - Marketsc...
Google News at Macroaxis
over two weeks ago at news.google.com         
Aarti Drugs Limited Receives Order in Form DRC-22 from Office of Joint Commissioner of State Tax, In...
Google News at Macroaxis
over three weeks ago at news.google.com         
Aarti Drugs Faces Significant Volatility Amidst Ongoing Performance Challenges - MarketsMojo
Google News at Macroaxis
over a month ago at news.google.com         
Aarti Drugs Hits 52-Week Low at Rs. 420, Declines 9.29 percent Over Six Days - MarketsMojo
Google News at Macroaxis
over a month ago at news.google.com         
Aarti Drugs Hits 52-Week Low of Rs. 417.95 Amid 21.43 percent Annual Decline - MarketsMojo
Google News at Macroaxis
over a month ago at news.google.com         
Aarti Drugs Receives Hold Rating Amid Declining Profits and Stable Financial Metrics - MarketsMojo
Google News at Macroaxis
over a month ago at news.google.com         
Aarti Drugs Shares Close 12 percent Higher After USFDA Issues VAI Tag For Tarapur Facility - NDTV Pr...
Google News at Macroaxis
over two months ago at news.google.com         
Aarti Drugs share buyback Last day to buy for eligibility - MSN
Google News at Macroaxis
over three months ago at news.google.com         
Aarti Drugs Receives Sell Rating from MarketsMOJO, Poor Growth and Bearish Trend Indicate Downgrade ...
Google News at Macroaxis
over three months ago at news.google.com         
Heres why Aarti Drugs shares fell 4 percent on October 25, more details here - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Indias Aarti Drugs falls as US FDA issues inspectional observations - XM
Google News at Macroaxis
over three months ago at news.google.com         
Aarti Drugs shares trade lower after 7 observations from USFDA - Moneycontrol
Google News at Macroaxis
over three months ago at news.google.com         
Stocks in news SpiceJet, Mankind Pharma, Vodafone Idea, Aarti Drugs, BHEL, RIL - MSN
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Aarti Drugs that are available to investors today. That information is available publicly through Aarti media outlets and privately through word of mouth or via Aarti internal channels. However, regardless of the origin, that massive amount of Aarti data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aarti Drugs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aarti Drugs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aarti Drugs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aarti Drugs alpha.

Aarti Drugs Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Aarti Drugs Hits 52-Week Low of Rs. 417.95 Amid 21.43 percent Annual Decline - MarketsMojo
01/14/2025
2
Aarti Drugs shares rose 12 percent in fag end of trade today, heres why - Business Today
02/14/2025

Additional Tools for Aarti Stock Analysis

When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.